ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) is one of 896 publicly-traded companies in the “Pharmaceuticals” industry, but how does it weigh in compared to its competitors? We will compare ARS Pharmaceuticals to similar businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, profitability, earnings and dividends. Risk and Volatility ARS […]